Fidelity Advisor Biotechnology Fund - Class C (FBTCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
20.91
-0.18 (-0.85%)
Mar 10, 2025, 10:54 AM EST
-12.66%
Fund Assets 2.85B
Expense Ratio 1.76%
Min. Investment $0.00
Turnover n/a
Dividend (ttm) 1.44
Dividend Yield 6.89%
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date Dec 26, 2024
Previous Close 21.09
YTD Return -0.76%
1-Year Return -12.66%
5-Year Return 29.36%
52-Week Low n/a
52-Week High n/a
Beta (5Y) n/a
Holdings 97
Inception Date Dec 27, 2000

About FBTCX

FBTCX was founded on 2000-12-27. The Fund's investment strategy focuses on Health/Biotech with 1.77% total expense ratio. The minimum amount to invest in Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund; Class C Shares is $0 on a standard taxable account. Fidelity Advisor Series VII: Fidelity Advisor Biotechnology Fund; Class C Shares seeks capital appreciation by investing at least 80% of its assets in equity securities of firms engaged in research, development, distribution, and manufacture of various biotech products, services, and processes and firms benefiting from advances in biotechnology. Issuers may be foreign or domestic.

Fund Family Fidelity
Category Health
Performance Rating Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol FBTCX
Share Class Class C
Index S&P 500 TR

Performance

FBTCX had a total return of -12.66% in the past year. Since the fund's inception, the average annual return has been 5.85%, including dividends.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
FIJYX Class Z 0.61%
FBTIX Class I 0.74%
FBTAX Class A 1.01%
FBTTX Class M 1.29%

Top 10 Holdings

57.80% of assets
Name Symbol Weight
AbbVie Inc. ABBV 21.42%
Regeneron Pharmaceuticals, Inc. REGN 6.23%
Amgen Inc. AMGN 5.86%
Alnylam Pharmaceuticals, Inc. ALNY 5.23%
Vertex Pharmaceuticals Incorporated VRTX 4.62%
argenx SE ARGX 4.52%
Ascendis Pharma A/S ASND 3.85%
Vaxcyte, Inc. PCVX 2.25%
Viridian Therapeutics, Inc. VRDN 1.93%
Nuvalent, Inc. NUVL 1.90%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 26, 2024 $1.441 Dec 27, 2024
Dec 17, 2021 $5.241 Dec 20, 2021
Jul 9, 2021 $0.006 Jul 12, 2021
Dec 18, 2020 $2.732 Dec 21, 2020
Dec 20, 2019 $1.849 Dec 23, 2019
Dec 7, 2018 $0.589 Dec 10, 2018
Full Dividend History